IMMUNOCELLULAR THERAPEUTICS (IMUC) Stock Price, Quote, News and Overview

What is the stock price of IMMUNOCELLULAR THERAPEUTICS today?

The current stock price of IMUC is 0.053 null. The price decreased by -75.91% in the last trading session.

What is the ticker symbol for IMMUNOCELLULAR THERAPEUTICS stock?

The exchange symbol of IMMUNOCELLULAR THERAPEUTICS is IMUC and it is listed on the NYSE Arca exchange.

On which exchange is IMUC stock listed?

IMUC stock is listed on the NYSE Arca exchange.

What is IMMUNOCELLULAR THERAPEUTICS worth?

IMMUNOCELLULAR THERAPEUTICS (IMUC) has a market capitalization of 2.22M null. This makes IMUC a Nano Cap stock.

Should I buy IMMUNOCELLULAR THERAPEUTICS (IMUC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of IMUC, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of IMUC, evaluating the profitability, health, valuation and growth aspects
• IMMUNOCELLULAR THERAPEUTICS (IMUC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• IMMUNOCELLULAR THERAPEUTICS (IMUC) Sales and EPS estimates to see what analysts future expectations are.
• IMMUNOCELLULAR THERAPEUTICS (IMUC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• IMMUNOCELLULAR THERAPEUTICS (IMUC) Insider and Institutional Ownership to learn about the owners and their transactions.
• IMMUNOCELLULAR THERAPEUTICS (IMUC) Stock Chart to make your own analysis
• IMMUNOCELLULAR THERAPEUTICS (IMUC) Latest news and press-releases to stay up to date.

Does IMMUNOCELLULAR THERAPEUTICS (IMUC) stock pay dividends?

IMUC does not pay a dividend.

What is the Price/Earnings (PE) ratio of IMMUNOCELLULAR THERAPEUTICS (IMUC)?

IMMUNOCELLULAR THERAPEUTICS (IMUC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.45).

What is the Short Interest ratio of IMMUNOCELLULAR THERAPEUTICS (IMUC) stock?

The outstanding short interest for IMMUNOCELLULAR THERAPEUTICS (IMUC) is 0% of its float. Check the ownership tab for more information on the IMUC short interest.

ChartMill assigns a fundamental rating of 2 / 10 to IMUC. IMUC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.

Over the last trailing twelve months IMUC reported a non-GAAP Earnings per Share(EPS) of -1.4500000000000002. The EPS increased by 86.7% compared to the year before.